van den Bogaard A E, Thijssen H H, Hemker H C
Tijdschr Diergeneeskd. 1985 Aug 15;110(15-16):585-95.
The anticoagulant, warfarin, has been reported to be effective as treatment for navicular disease in horses. Since other forms of treatment for this disease are palliative, this new anticoagulant therapy has become widely employed. Despite the fact that initiation of anticoagulant therapy is relatively simple, attending veterinary practitioners should be aware that careful monitoring of this therapy is required for both safety and efficacy. Navicular disease is an example of equine thrombotic disease, and the goal of warfarin therapy is the prevention of new thrombus formation, while at the same time preserving haemostasis. This paper presents a review of the mechanisms of action of warfarin, its beneficial effects, its potential for toxicity in horses, and the interaction of warfarin and other drugs. Laboratory monitoring of the therapy and vitamin K-1 treatment in case of overdosing are discussed.
据报道,抗凝血剂华法林对治疗马的舟状骨病有效。由于该疾病的其他治疗方式只是缓解性的,这种新的抗凝血剂疗法已被广泛应用。尽管启动抗凝血剂疗法相对简单,但执业兽医应意识到,为了安全和疗效,需要对该疗法进行仔细监测。舟状骨病是马血栓性疾病的一个例子,华法林疗法的目标是预防新的血栓形成,同时保持止血功能。本文综述了华法林的作用机制、其有益效果、在马体内的潜在毒性以及华法林与其他药物的相互作用。还讨论了该疗法的实验室监测以及过量用药时的维生素K-1治疗。